Investing in the Future of Global Health
Saudi Arabia is rapidly becoming a global destination for biotech investment and innovation – powered by national platforms and institutional capital deployed through leading subsidiaries of the Public Investment Fund (PIF).
Zone 5 offers a window into how these pioneering entities are advancing the Kingdom’s vision for health sovereignty and sector leadership. From building advanced biomanufacturing capacity to enabling data-driven precision medicine, these platforms are accelerating localization and unlocking new frontiers for global partnerships.
Strategic Investment in National and Global Health
With a mandate to drive sustainable impact, these subsidiaries are not only strengthening domestic capabilities, but also creating investable opportunities for international companies across the life sciences value chain.
Zone 5 captures Saudi Arabia’s strategic approach: leveraging capital, talent, and technology to transform the future of health—at home and on the world stage.
Key areas of focus include:
Scaling pharmaceutical and biologics manufacturing
Advancing health data infrastructure and AI-driven solutions
Investing in national champions that drive innovation and impact
Facilitating international partnerships across R&D and commercialization
Through long-term investments and visionary execution, PIF is positioning Saudi Arabia as a regional hub and global contributor in biotech and health innovation.
Digital Health Transformation Leader: Lean Business Services
Lean, a PIF-owned digital health company, is transforming the way health services are delivered and managed in Saudi Arabia. It builds secure, interoperable digital platforms that connect healthcare providers, regulators, and patients by empowering data-driven policy, personalized care, and health system efficiency.
Lean’s contributions to the biotech and life sciences space include:
Building nationwide health data platforms that support clinical research and real-world evidence generation
Enabling digital integration between research institutions, regulators, and care providers
Providing APIs and services that streamline health innovation and startup scaling
For biotech innovators, Lean offers a robust data backbone that accelerates trial design, health analytics, and regulatory intelligence.
:quality(80))
Biotech and Life Sciences Champion: Lifera
Lifera is the dedicated life sciences investment and operating company established by PIF to anchor Saudi Arabia’s global biotech ambitions. It serves as a national platform for R&D, biologics manufacturing, and health innovation partnerships by bridging local need with global opportunity.
Lifera’s mission includes:
Driving investment in therapeutics, diagnostics, and biopharma manufacturing
Launching and scaling joint ventures with multinational biotech and pharma players
Supporting clinical research and localization of advanced health technologies
Catalyzing the emergence of a regional biotech hub based in Saudi Arabia
Lifera offers strategic partnership opportunities for global companies looking to enter or expand in the region. Backed by institutional capital, local insight, and national alignment.
:quality(80)){kind=logo}
A Zone of Scale, Vision, and Strategic Capital
Zone 5 represents more than investment; it reflects Saudi Arabia’s intent to lead globally by building locally. Through PIF subsidiaries, the Kingdom is creating the infrastructure, partnerships, and momentum needed to become a biotech powerhouse.
For biotech executives, investors, pharma leaders, and research institutions, Zone 5 is where scale meets purpose, and where your next breakthrough can find long-term backing.
:quality(80))
Saudi Arabia: The Global Biotech Hub
Discover a high-demand market powered by regulatory reform, national R&D strength, and strategic investment. Explore how infrastructure and data platforms are unlocking new opportunities across the biotech value chain.
:quality(80))
Multinationals: Launchpad for Innovation
Accelerate trials, scale manufacturing, and unlock new markets. With speed to approval, real-world evidence, and built-in localization support, Saudi Arabia is where biotech goes further, faster.